China's Domestically Developed Oral COVID-19 Medicine Manufacturing In Haikou

HAIKOU, CHINA - FEBRUARY 11: Employees work on the production line of drug "XIANNUOXIN", which is intended to be used for the treatment of adults infected with mild to moderate COVID-19, at a workshop of Simcere Pharmaceutical Group on February 11, 2023 in Haikou, Hainan Province of China. The drug was jointly developed by the Group with the Shanghai Institute of Materia Medica, Wuhan Institute of Virology and the Chinese Academy of Medical Sciences. (Photo by VCG/VCG via Getty Images)
HAIKOU, CHINA - FEBRUARY 11: Employees work on the production line of drug "XIANNUOXIN", which is intended to be used for the treatment of adults infected with mild to moderate COVID-19, at a workshop of Simcere Pharmaceutical Group on February 11, 2023 in Haikou, Hainan Province of China. The drug was jointly developed by the Group with the Shanghai Institute of Materia Medica, Wuhan Institute of Virology and the Chinese Academy of Medical Sciences. (Photo by VCG/VCG via Getty Images)
China's Domestically Developed Oral COVID-19 Medicine Manufacturing In Haikou
PURCHASE A LICENSE
How can I use this image?
kr 2,500.00
NOK
Getty ImagesChina's Domestically Developed Oral COVID-19 Medicine Manufacturing..., News PhotoChina's Domestically Developed Oral COVID-19 Medicine Manufacturing..., News PhotoChina's Domestically Developed Oral COVID-19 Medicine Manufacturing... Get premium, high resolution news photos at Getty ImagesProduct #:1465593451
kr4,000kr950
Getty Images
In stock

DETAILS

Restrictions:
Contact your local office for all commercial or promotional uses.(CHINA OUT)
Credit:
VCG / Contributor
Editorial #:
1465593451
Collection:
Visual China Group
Date created:
February 11, 2023
Upload date:
License type:
Rights-managed
Release info:
Not released. More information
Source:
Visual China Group
Object name:
vcg111422326467
Max file size:
7170 x 4780 px (23.90 x 15.93 in) - 300 dpi - 17 MB